Premier Logo

White Paper

Premier Healthcare Database (COVID-19): Data that Informs and Performs

As the number of infected patients and deaths continue to rise globally, clinicians, scientists and researchers worldwide are struggling to understand all facets of COVID-19. Having sufficient data is the first step to evaluating the impact of COVID-19 and designing adequate local and national public health responses for the management and containment of this pandemic. The Premier Healthcare Database (PHD) is equipped with HIPAA-compliant, de-identified patient data to support COVID-19-related research needs.

Whether your organization is interested in evaluating novel testing and treatment options, supplying health systems with life-saving medications and equipment, or in ensuring patients are able to continue to manage their chronic conditions, download this white paper for a detailed description of the attributes and capabilities of the PHD as it relates to COVID-19 data.


Premier is committed to protecting the privacy and security of any personal information you provide to us. By clicking here, you understand and acknowledge that the personal information that you are submitting on this form is subject to Premier's privacy policy and may be shared with third parties.

Privacy Policy